Zachariah McIver - Jan 1, 2025 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Signature
/s/ James Pennington, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Jan 1, 2025
Transactions value $
$0
Form type
3
Date filed
1/3/2025, 08:00 PM
Next filing
Jan 3, 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on June 1, 2024 and the balance of the shares vest in equal monthly installments thereafter over a three year period.
F2 25% of the shares subject to the option vest on January 1, 2025 and the balance of the shares vest in equal monthly installments thereafter over a three year period.